4//SEC Filing
Neos Therapeutics, Inc. 4
Accession 0001104659-15-053974
CIK 0001467652operating
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 8:32 PM ET
Size
20.4 KB
Accession
0001104659-15-053974
Insider Transaction Report
Form 4
Kearny Venture Assoicates II LLC
10% Owner
Transactions
- Conversion
Common Stock
2015-07-28+561,938→ 1,215,052 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2015-07-28−432,523→ 0 total(indirect: See Footnote)→ Common Stock (180,217 underlying) - Conversion
Series B-1 Preferred Stock
2015-07-28−1,134,954→ 0 total(indirect: See Footnote)→ Common Stock (472,897 underlying) - Conversion
Series C Preferred Stock
2015-07-28−1,348,655→ 0 total(indirect: See Footnote)→ Common Stock (561,938 underlying) - Conversion
Common Stock
2015-07-28+180,217→ 180,217 total(indirect: See Footnote) - Conversion
Common Stock
2015-07-28+472,897→ 653,114 total(indirect: See Footnote)
Footnotes (2)
- [F1]Each share of the Issuer's Series B preferred stock, Series B-1 preferred stock and Series C preferred stock was automatically converted on a 2.4-for-1 basis into common stock immediately prior to the closing of the Issuer's initial public offering (prior to the Company's 2.4-for-1 reverse common stock split the preferred stock would have converted on a 1-for-1 basis pursuant to its terms). The shares of Series B preferred stock, Series B-1 preferred stock and Series C preferred stock had no expiration date.
- [F2]The security listed in column 1 is held directly by Burrill Life Sciences Capital Fund III, L.P. ("Burrill"). Kearny Venture Associates II, LLC ("KVA II"), is the General Partner of Burrill. Caley Castelein and Anupam Dalal are the managing members of KVA II and share both voting power and disposal power over the shares. Each Reporting Person disclaims beneficial ownership of the Securities, except to the extent of its pecuniary interest therein.
Documents
Issuer
Neos Therapeutics, Inc.
CIK 0001467652
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001467652
Filing Metadata
- Form type
- 4
- Filed
- Jul 27, 8:00 PM ET
- Accepted
- Jul 28, 8:32 PM ET
- Size
- 20.4 KB